Tumor twitter: Cellular communication in the breast cancer stem cell niche

Cancer Discovery

Volumn 5, Issue 5, 2015, Pages 469-471

  Brooks, Michael D ^a   Wicha, Max S ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN P53; STROMAL CELL DERIVED FACTOR 1; WNT2 PROTEIN; WNT9A PROTEIN;

ARTICLE; BREAST CANCER; CELL COMMUNICATION; DNA SEQUENCE; EPIGENETICS; GENE EXPRESSION; MICROARRAY ANALYSIS; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT; ANIMAL; BREAST TUMOR; FEMALE; GENETICS; HUMAN; METABOLISM;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84979993218     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-15-0327     Document Type: Article

References (10)

1. Easwaran H, Tsai HC, Baylin SB. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell 2014; 54: 716–27.
2. Liu S, Cong Y, Wang D, Sun Y, Deng L, Liu Y, et al. Breast cancer stem cells transition between epithelial and mesenchymal states refl ective of their normal counterparts. Stem Cell Rep 2014; 2: 78–91.
3. Place AE, Jin Huh S, Polyak K. The microenvironment in breast cancer progression: biology and implications for treatment. Breast Cancer Res 2011; 13: 227.
4. Plaks V, Kong N, Werb Z. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? Cell Stem Cell 2015; 16: 225–38.
5. Marusyk A, Tabassum DP, Altrock PM, Almendro V, Michor F, Polyak K. Non–cell-autonomous driving of tumour growth supports subclonal heterogeneity. Nature 2014; 514: 54–8.
6. Zhang M, Tsimelzon A, Chang C-H, Fan C, Wolff A, Perou CM, et al. Intratumoral heterogeneity in a Trp53 -null mouse model of human breast cancer. Cancer Discov 2015; 5: 520–33.
7. Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, Edwards D, et al. Identifi cation of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res 2008; 68: 4674–82.
8. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 2010; 12: R68.
9. Fillmore CM, Gupta PB, Rudnick JA, Caballero S, Keller PJ, Lander ES, et al. Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc Natl Acad Sci U S A 2010; 107: 21737–42.
10. Rajaram RD, Buric D, Caikovski M, Ayyanan A, Rougemont J, Shan J, et al. Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. EMBO J 2015; 34: 641–52.